-

Additional Information on the Compensation and the Financial Conditions of the Termination of Mr. Yves Le Masne as CEO of ORPEA

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News:

In addition to the financial conditions of the termination of Mr. Yves Le Masne as Chief Executive Officer of ORPEA (Paris:ORP) as decided by the Board of Directors and published on January 30, 2022, the Board of Directors of April 28, 2022 took the following decisions on the recommendations of the Appointments and Remuneration Committee.

They take into account, in particular, the crisis faced by the Group and its stakeholders since the publication of a book containing allegations of dysfunctions.

i) 2021 Annual variable compensation

On the basis of the quantifiable and qualitative criteria set out in the compensation policy approved by the 2021 Shareholders' Meeting, the gross annual variable compensation of Mr. Yves Le Masne for the fiscal year ending December 31, 2021 would amount € 563,666.67.

The payment of this variable annual compensation to Mr. Yves Le Masne is subject to the approval of the resolution relating to the 2021 compensation of the Chief Executive Officer, which will be submitted to the 2022 Shareholders' Meeting, in accordance with Article L. 22-10-34 of the French Commercial Code.

The Board of Directors will recommend shareholders not to approve such resolution. If such resolution is rejected, no variable compensation will be paid to him.

ii) 2019, 2020 and 2021 performance shares plans

The Board of Directors has decided not to exercise its option to waive the presence condition in certain performance share plans.

Mr. Yves Le Masne has therefore lost all vested rights as of the date of termination of his CEO duties under the 2019, 2020 and 2021 plans.

iii) Compensation policy for 2022

The Board of Directors has decided not to provide for a severance payment in the compensation policy applicable to Mr. Yves Le Masne as from January 1, 2022. Subject to the approval by the Shareholders' Meeting 2022 of this remuneration policy, Mr. Yves Le Masne will not receive any indemnity for the termination of his CEO duties.

It is reminded that Mr. Yves Le Masne does not benefit from any specific supplementary pension scheme or indemnities in consideration of a non-competition undertaking.

It is also recalled that the 2022 compensation policy would only provide for the granting to Mr. Yves Le Masne of the fixed part of his annual compensation on a prorata temporis basis, to the exclusion of any variable compensation, in addition to the other benefits of any kind enjoyed by Mr. Yves Le Masne (unemployment insurance, company car and application of the collective provident and health plans) until January 30, 2022.

About ORPEA (www.orpea-corp.com)

Founded in 1989, ORPEA is one of the world leaders in Dependency care (nursing homes, assisted living, post-acute and rehabilitation hospitals, mental health hospitals, home care services)

ORPEA is listed on Euronext Paris (ISIN code: FR0000184798) and is a member of the SBF 120, STOXX 600 Europe, MSCI Small Cap Europe and CAC Mid 60 indices.

Contacts

Investor Relations
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
Tel.: +33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr

Caroline Simon
Tél.: +33(0)6 89 87 61 24
Caroline.simon@image7.fr

ORPEA

BOURSE:ORP

Release Versions

Contacts

Investor Relations
ORPEA
Benoit Lesieur
Investor Relations Director
b.lesieur@orpea.net

Investor Relations
NewCap
Dusan Oresansky
Tel.: +33 (0)1 44 71 94 94
orpea@newcap.eu

Media Relations
Image 7
Charlotte Le Barbier
Tel.: +33 (0)6 78 37 27 60
clebarbier@image7.fr

Caroline Simon
Tél.: +33(0)6 89 87 61 24
Caroline.simon@image7.fr

More News From ORPEA

De-leveraging continues: emeis sells its nursing home business in Switzerland for nearly €270 million

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: emeis (Paris:EMEIS) has finalized sales agreements with Tertianum, a Swiss operator specializing in care and support for the elderly, and two institutional real estate investors. These agreements cover nursing home activities in Switzerland and the associated real estate assets, for a total value of CHF 250 million1, or nearly €270 million. This new transaction brings the volume of disposals completed or secured since mid-2022 to nearly €2.4 bi...

emeis: Refinancing and Extension of Debt Maturity

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Emeis SA (Paris:EMEIS), together with its main banking partners and financial investors1, has approved the terms of an agreement in principle for the refinancing of the bank debt of emeis SA and its subsidiaries Niort 94 and Niort 95, subject to obtaining all the agreements of the credit committees of the institutions concerned and finalization of the contractual documentation. This refinancing will increase the average maturity of the debt by...

emeis Sells Its Independent Senior Residences Business in France for Nearly €160 Million

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: On October 31, 2025, emeis (Paris:EMEIS) finalized the sale of its independent senior residences in France and related real estate to a real estate fund managed by TwentyTwo Real Estate as the lead investor and Azora Capital. This transaction is part of emeis' strategy to refocus and reduce its debt. It has been carried out without affecting the continuity and quality of service for residents and without any impact on the employment of the team...
Back to Newsroom